Status:
UNKNOWN
Generalized Training Program for Caregivers on the ESDM: PEGASE
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
2-4 years
Phase:
NA
Brief Summary
The main objective of the study is to evaluate the effectiveness of a parent's training program (name PEGASE) of young children (aged 2 to 4 years) with Autism Spectrum Disorders. This study is follo...
Eligibility Criteria
Inclusion
- Children aged 2 to 4 years
- Child diagnosed with the clinical criteria of The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and International Classification of Diseases 10th Revision (ICD 10). Initial diagnosis of Autism spectrum disorder (ASD) should be validated by recommended diagnostic scales: ADI R, ADOS 2.
- A child whose parents or legal representatives have accepted their child's participation in this study, and have signed informed consent.
Exclusion
- No presentation to initial and final evaluations
- Withdrawal of informed consent (which can intervene at any time of the study and without proof)
Key Trial Info
Start Date :
November 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 7 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03769571
Start Date
November 8 2018
End Date
November 7 2021
Last Update
December 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de pédopsychiatrie Sainte-Marguerite
Marseille, Marseille Cedex 09, France, 13274